Groups Call for FDA to Maintain Independent Authority, Transparency in COVID-19 Vaccine Approvals
In a letter to U.S. Food and Drug Administration leaders today, more than 90 organizations representing physicians and other health providers, as well as scientists, patients and medical advocates, urge the agency to ensure that reviews of COVID-19 vaccine candidates meet all regulatory standards prior to authorization or licensure.
The 75th United Nations General Assembly Opening Underscores Needs for Multilateral Health Responses
As the United Nations General Assembly opens for the first time in its 75-year history without an on-site gathering of world leaders, the critical need for international collaboration to end the current pandemic and prevent the next one should be clearer and more compelling than ever.
Infectious Diseases and HIV Specialists Call for Urgent Policy Action to Reduce Harms of Injection Drug Use During the COVID-19 Pandemic
In a new policy paper, IDSA and HIVMA call for urgent action to reduce illness and death associated with the overlapping epidemics of injection drug use and infectious diseases, outlining key steps needed now more than ever during the COVID-19 pandemic.
Infectious Diseases Specialists to FDA: Don’t Cut Corners in COVID-19 Vaccine Approval
The Infectious Diseases Society of America and its HIV Medicine Association are urging the Food and Drug Administration to ensure rigorous safety and efficacy data support the approval of a COVID-19 vaccine before its widespread use by the public.
IDSA/HIVMA Statement on Changes to CDC Guidance
IDSA and HIVMA call for the immediate reversal of the abrupt revision of the CDC COVID-19 testing guidelines which diminish the importance of testing asymptomatic individuals who were exposed to COVID-19. The revision is concerning, particularly as the United States continues to lead the world in confirmed cases and deaths, with more than 5.8 million cases and nearly 180,000 lives lost to the virus.
Three Decades of the Ryan White HIV/AIDS Program Have Set an Example, and a Path Forward
Today we mark the 30th anniversary of the Ryan White HIV/AIDS Program, a lifesaving program passed as the Ryan White Comprehensive AIDS Resources Emergency (CARE) Act by Congress in 1990 with overwhelming bipartisan support, in response to a deadly virus made all the more destructive by stigma and misinformation.
As COVID-19 Cases Approach 5 Million in U.S., Infectious Diseases Leaders Call on White House for Unified Action on Masks
In a letter sent to Vice President Mike Pence today, leaders of the Infectious Diseases Society of America and its HIV Medicine Association are urging the White House to issue a strong federal directive calling for mask requirements in all states to curtail the spread of COVID-19 across this country, protect the economy and safely reopen schools.
IDSA, HIVMA Urge Inclusion of People Living with HIV in COVID-19 Clinical Trials
In a letter sent Wednesday to officials heading federal efforts to develop a vaccine against COVID-19, leaders of the Infectious Diseases Society of America and its HIV Medicine Association have urged that participation in clinical trials of vaccine candidates be open to people living with HIV.
Senate Republican COVID-19 Relief Responses Represent Progress but Fall Short of Critical Needs
A series of proposed COVID-19 bills released by Senate Republicans Monday represent a step toward urgently needed relief and resources, but fall short of necessary responses.
HIVMA Chair on Rep. John Lewis’ Commitment to Health Equity & HIV
Congressman John Lewis was a hero and leader like no other. His unwavering fight for civil rights and health equity included a special commitment to conquering HIV